bpc-157 ulcerative colitis clinical trial phase ii 544 published articles on BPC-157. 36 met inclusion criteria for a 2025 systematic review. 35 were animal studies. One was clinical. Twelve patients. Seven reported pain relief. No control group. That is Stable gastric pentadecapeptide BPC 157
Description
doi: 10.3109/03009738709178677
This depends on the dose and how much water was added: 5mg vial at 250mcg/dose = 20 doses 5mg vial at 500mcg/dose = 10 doses 10mg vial at 250mcg/dose = 40 doses 10mg vial at 500mcg/dose = 20 doses At the community-reported common protocol of 250mcg twice daily, a 5mg vial lasts 10 days
BPC-157 is a synthetic peptide composed of 15 amino acids, hence the term stable gastric pentadecapeptide. It is a partial copy of a sequence linked to a protein found in gastric juice
[DOI] [PubMed] [Google Scholar] 126.Gorrindo P., Lane C.J., Lee E.B., McLaughlin B., Levitt P
